Reframing the role of glucagon‐like peptide 1 receptor agonists in cardiovascular medicine
ESC Heart Failure, Volume 12, Issue 2, Page 923-926, April 2025.
Riccardo M. Inciardi +3 more
wiley +1 more source
Waiting Time Prioritisation for Public and Private Providers: Evidence From Hip Replacement Surgery
ABSTRACT Waiting times for planned health care treatments have been increasing in England and other OECD countries. One policy to reduce the impact of waiting times on patients' health is for doctors to prioritise patients according to their health status. This study tests the extent to which publicly‐funded patients in poorer health are prioritised on
Panos Kasteridis +2 more
wiley +1 more source
Diagnostic and management challenges of severe heart failure with reduced ejection fraction in a patient with extreme morbid obesity: a case report. [PDF]
Mansoor M +4 more
europepmc +1 more source
Cardiac Resynchronization Therapy Optimization in a Patient with Left Ventricular Non-Compaction Cardiomyopathy and Morbid Obesity. [PDF]
Farhangee A, Mindrila I.
europepmc +1 more source
Urological Complications of Morbid Obesity and the Role of Bariatric Surgery and Glucagon-Like Peptide-1 Receptor Agonists in Their Management: A Systematic Review. [PDF]
Khalil W +4 more
europepmc +1 more source
Simultaneous surgical treatment of morbid obesity and end-stage achalasia: a case report and review of literature. [PDF]
Costantini A +9 more
europepmc +1 more source
Extended Panniculectomy as a Bridge to Renal Transplantation in a Patient With Morbid Obesity: A Case Report. [PDF]
Hernández-Mancillas EM +3 more
europepmc +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala +1 more
wiley +1 more source
Intravenous Sedation of a Patient With Morbid Obesity and Severe Sleep Apnea Syndrome for Dental Treatment: A Case Report. [PDF]
Onozawa T, Hase Y, Kimura Y, Kido K.
europepmc +1 more source

